Polymorphism of Thyroid Hormones Receptor, Angiotensin-Converting Enzyme, and High Blood Pressure in Childbearing Age Women with Hyperthyroidism
DOI:
https://doi.org/10.3889/oamjms.2021.6193Keywords:
Polymorphism, Blood pressure, Angiotensin-converting enzyme I/D, THRA, Renin-angiotensin system, Thyroid hormone, HyperthyroidismAbstract
AIM: This study aimed to investigate the association between two polymorphisms of thyroid hormone receptor and renin-angiotensin system (THRA C/T and angiotensin-converting enzyme (ACE) I/D) genes with hypertension in childbearing age women with hypertension.
METHODS: This was a case–control study including 35 cases and 40 matched control subjects. The case group was hyperthyroid women with hypertension while the control group was hyperthyroid women with normotension. The polymorphisms were identified by a classical polymerase chain reaction.
RESULTS: The THRA C/T gene and ACE I/D polymorphisms were not associated with the hypertension while the genotype frequencies in hyperthyroid women with hypertension were as follows: CC genotype was 25.71%, CT genotype was 54.29%, and TT genotype was 20.00%. The ACE I/D genotype frequencies in hyperthyroid women with hypertension were as follows: II genotype was 23.53%, whereas in hyperthyroid women without hypertension, the I/D genotype frequencies were CC: 7.50%, CT: 72.50%, and TT: 20.00%. There were no differences in age, thyroid-stimulating hormone, FT4, systolic blood pressure (SBP), diastolic BP between subgroups in ACE I/D, and at THRA rs-939348. There was a significant difference in the levels of FT4 concentrations in THRA rs-939348. Hypertension groups have higher SBP than controls. Genotype II had higher SBP but it was not statistically significant, while individuals with allele I had SBP higher than D allele.
CONCLUSIONS: The I allele of the ACE gene is involved in susceptibility to hypertension and polymorphism in THRA increasing concentration of FT4. There was no statistically significant difference in blood pressure between hyperthyroid women with or without hypertension.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Heshmat H, El Taib S. The role of endurance exercise program inhyperthyroidism in relation to ACE genotype. J Am Sci. 2013;9(2):372-6.
Zhang J, Lazar MA. The mechanism of action of thyroid hormones. Annu Rev Physiol. 2000;62(1):439-66. PMid:10845098
Wenger NK, Arnold A, Bairey Merz CN, Cooper-DeHoff RM, Ferdinand KC, Fleg JL, et al. Hypertension across a woman’s life cycle. J Am Coll Cardiol. 2018;71(16):1797-813. https://doi.org/10.1016/j.jacc.2018.02.033 PMid:29673470
Sinha S, Kar K. Single nucleotide polymorphism of thyroid hormone receptor α _gene can be a risk of atherogenic dyslipidemia. J Clin Diagnostic Res. 2018;12(9):BC01-4. https://doi.org/10.7860/jcdr/2018/34904.11974
Goumidi L, Gauthier K, Legry V, Mayi TH, Houzet A, Cottel D, et al. Association between a thyroid hormone receptor-α _gene polymorphism and blood pressure but not with coronary heart disease risk. Am J Hypertens. 2011;24(9):1027-34. https://doi.org/10.1038/ajh.2011.94 PMid:21654857
Martınez E, Puras A, Escribano J, Sanchis C, Carrion L, Artigao M, et al. Angiotensin-converting enzyme (ACE) gene polymorphisms, serum ACE activity and blood pressure in a Spanish-mediterranean population. J Hum Hypertens. 2000;14(2):131-5. https://doi.org/10.1038/sj.jhh.1000958 PMid:10723120
Okumuş S, Demiryürek Ş, Özkur M, Coşkun E, Tatar MG, Erbaǧci I, et al. No major impact of insertion/deletion polymorphism of the angiotensin-converting enzyme gene on thyroid-associated ophthalmopathy. Turkish J Med Sci. 2013;43(3):436-40. https://doi.org/10.3906/sag-1207-113
Hernando VU, Eliana MS. Endocrinology and metabolic syndrome. Endocrinol Metab Synd. 2015;4(2):661-9.
Rivolta CM, Olcese MC, Belforte FS, Chiesa A, Gruneiro- Papendieck L, Iorcansky S, et al. Genotyping of resistance to thyroid hormone in South American population. Identification of seven novel missense mutations in the human thyroid hormone receptor beta gene. Mol Cell Probes. 2009;23(3-4):148-53. PMid:19268523
Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725-35. PMid:17923583
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-34. https://doi.org/10.1001/archinte.160.4.526 PMid:10695693
Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep. 2003;5(6):513-20. PMid:14594573
Jeunemaitre X, Bassilana F, Persu A, Dumont C, Champigny G, Lazdunski M, et al. Genotype-phenotype analysis of a newly discovered family with Liddle’s syndrome. J Hypertens. 1997;15(10):1091-100. PMid:9350583
Siyad AR. Hypertension. Hygeia J D Med. 2011;3(1):1-16.
Butler MG. Pediatric hypertension: Genetics of hypertension current status. J Med Liban. 2010;58(3):175-8.
Singh KD, Jajodia A, Kaur H, Kukreti R, Karthikeyan M. Gender specific association of RAS gene polymorphism with essential hypertension: A case-control study. Biomed Res Int. 2014;2014:538053. https://doi.org/10.1155/2014/538053 PMid:24860821
Singh M, Singh AK, Singh S, Pandey P, Chandra S, Gambhir IS, et al. Angiotensin-converting enzyme gene I/D polymorphism increases the susceptibility to hypertension and additive diseases : A study on North Indian patients. Clin Exp Hypertens. 2016;38(3):305-11. https://doi.org/10.3109/10641963.2015.1107085 PMid:27030424
Niu W, Qi Y, Cen W, Cui C, Zhuoma C. Genetic polymorphisms of angiotensinogen and essential hypertension in a tibetan population. Hypertens Res. 2007;30(11):1129-37. https://doi.org/10.1291/hypres.30.1129 PMid:18250562
Singh M, Pandey P, Singh AK, Chandra S, Singh KA, Gambhir IS. Molecular genetics of essential hypertension. Clin Exp Hypertens. 2016;38(3):268-77. https://doi.org/10.3109/10641963.2015.1116543 PMid:27028574
Gupta S, Agrawal B, Goel R, Sehajpal PK. Angiotensin-converting enzyme gene polymorphism in hypertensive rural population of Haryana, India. J Emerg Trauma Shock. 2009;2(3):150. https://doi.org/10.4103/0974-2700.55323 PMid:20009302
Tchelougou D, Kologo JK, Karou SD, Yaméogo VN, Bisseye C, Djigma FW, et al. Renin-angiotensin system genes polymorphisms and essential hypertension in Burkina Faso, West Africa. Int J Hypertens. 2015;2015:979631. https://doi.org/10.1155/2015/979631 PMid:26351579
Rasyid H, Bakri S, Yusuf I. Angiotensin-converting enzyme gene polymorphisms, blood pressure and pulse pressure in subjects with essential hypertension in a South Sulawesi Indonesian population. Acta Med Indones. 2012;44(4):280-3. PMid:23314967
Krishnan R, Sekar D, Karunanithy S, Subramanium S. Association of angiotensin converting enzyme gene insertion/ deletion polymorphism with essential hypertension in south Indian population. Genes Dis. 2016;3(2):159-63. https://doi.org/10.1016/j.gendis.2016.03.001 PMid:30258884
Olateju TO, Vanderpump MP. Thyroid hormone resistance. Ann Clin Biochem. 2006;43(6):431-40. https://doi.org/10.1258/000456306778904678 PMid:17132274
Rebaï M, Kallel I, Rebaï A. Genetic features of thyroid hormone receptors. J Genet. 2012;91(3):367-74. https://doi.org/10.1007/s12041-012-0179-x PMid:23271024
Goumidi L, Flamant F, Lendon C, Galimberti D, Pasquier F, Scarpini E, et al. Study of thyroid hormone receptor alpha gene polymorphisms on Alzheimer’s disease. Neurobiol Aging. 2011;32(4):624-30. https://doi.org/10.1016/j.neurobiolaging.2009.04.007 PMid:19427062
Sørensen HG, Van Der Deure WM, Hansen PS, Peeters RP, Breteler MM, Kyvik KO, et al. Identification and consequences of polymorphisms in the thyroid hormone receptor alpha and beta genes. Thyroid. 2008;18(10):1087-94. https://doi.org/10.1089/thy.2008.0236 PMid:18844476
Downloads
Published
How to Cite
License
Copyright (c) 2021 Agus Wibowo, Pramudji Hastuti, Vinayanti Susanti (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)
